2019 ACR/ARP Annual Meeting*

Download All
November 8-13, 2019; Atlanta, Georgia
Review the latest RA management data with Capsule Summaries and expert-authored commentaries covering key studies from ACR 2019.
Stanley B. Cohen, MD
Jonathan Kay, MD

ClinicalThought

MACE and VTE data were presented for all approved and phase III JAK inhibitors.

Stanley B. Cohen, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 5, 2019 Expired: No longer available for credit

Here’s how new strategies like ultralow-dose rituximab, a novel small molecule IRAK-4 inhibitor, and vagus nerve stimulation may or may not change clinical practice.

Jonathan Kay, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 9, 2020 Expired: No longer available for credit
Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences
Mallinckrodt Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue